Innovation Engine

We have state-of-the-art technology and manufacturing
platforms to repeatedly innovate with speed

Antibody Discovery and Development
In-house capabilities from early discovery to GMP manufacturing
Vaccine Technology
Innovative and highly differentiated “personalized” and “off-the-shelf” vaccines
Adaptive Learning Platform Systems (ALPS)
Artificial Intelligence (AI) based R&D platform to expand new molecular targets for cancer therapy
GMP Manufacturing Facility
(Berkeley, Ca, USA)
A key driver of rapid development that helps us advance faster than our peers
Cell Line Development Facility
(Cambridge, UK)
Key to execute rapid drug development